| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 585 | 2017 |
| Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial JF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ... The Lancet Neurology 20 (7), 526-536, 2021 | 274 | 2021 |
| Evaluation and construction of diagnostic criteria for inclusion body myositis TE Lloyd, AL Mammen, AA Amato, MD Weiss, M Needham, ... Neurology 83 (5), 426-433, 2014 | 230 | 2014 |
| Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of … P Narayanaswami, M Weiss, D Selcen, W David, E Raynor, G Carter, ... Neurology 83 (16), 1453-1463, 2014 | 218 | 2014 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 186 | 2019 |
| Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial GI Wolfe, HJ Kaminski, IB Aban, G Minisman, HC Kuo, A Marx, P Ströbel, ... The Lancet Neurology 18 (3), 259-268, 2019 | 176 | 2019 |
| Autoantibodies associated with peripheral neuropathy RH Quarles, MD Weiss Muscle & Nerve: Official Journal of the American Association of …, 1999 | 163 | 1999 |
| ADCY5-related dyskinesia: Broader spectrum and genotype–phenotype correlations DH Chen, A Méneret, JR Friedman, O Korvatska, A Gad, ES Bonkowski, ... Neurology 85 (23), 2026-2035, 2015 | 121 | 2015 |
| Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial BJ Wainger, EA Macklin, S Vucic, CE McIlduff, S Paganoni, NJ Maragakis, ... JAMA neurology 78 (2), 186-196, 2021 | 101 | 2021 |
| Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma MD Weiss, CA Luciano, C Semino-Mora, MC Dalakas, RH Quarles Neurology 51 (6), 1738-1741, 1998 | 100 | 1998 |
| A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression MD Weiss, EA Macklin, Z Simmons, AS Knox, DJ Greenblatt, N Atassi, ... Neurology 86 (16), 1474-1481, 2016 | 97 | 2016 |
| CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene DH Chen, Y Sul, M Weiss, A Hillel, H Lipe, J Wolff, M Matsushita, ... Neurology 75 (22), 1968-1975, 2010 | 86 | 2010 |
| Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia MD Weiss, MC Dalakas, CJ Lauter, HJ Willison, RH Quarles Journal of neuroimmunology 95 (1-2), 174-184, 1999 | 86 | 1999 |
| SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve CL Bennett, AJ Shirk, HM Huynh, VA Street, E Nelis, L Van Maldergem, ... Annals of Neurology: Official Journal of the American Neurological …, 2004 | 80 | 2004 |
| Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials GT Carter, ME Abood, SK Aggarwal, MD Weiss American Journal of Hospice and Palliative Medicine® 27 (5), 347-356, 2010 | 79 | 2010 |
| Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study GT Carter, MD Weiss, JS Lou, MP Jensen, RT Abresch, TK Martin, ... American Journal of Hospice and Palliative Medicine® 22 (1), 55-59, 2005 | 74 | 2005 |
| Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy DR Bisset, EA Stepniak-Konieczna, M Zavaljevski, J Wei, GT Carter, ... Human molecular genetics 24 (17), 4971-4983, 2015 | 66 | 2015 |
| Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study JF Howard, S Bresch, A Genge, C Hewamadduma, J Hinton, Y Hussain, ... The Lancet Neurology 22 (5), 395-406, 2023 | 62 | 2023 |
| Clinical and electrodiagnostic features of sciatic neuropathies BJ Distad, MD Weiss Physical Medicine and Rehabilitation Clinics 24 (1), 107-120, 2013 | 60 | 2013 |
| The amyotrophic lateral sclerosis center: a model of multidisciplinary management AS Mayadev, MD Weiss, BJ Distad, LS Krivickas, GT Carter Physical Medicine and Rehabilitation Clinics of North America 19 (3), 619-631, 2008 | 59 | 2008 |
